India accounts for approximately 25 per cent of the world’s β-thalassemia cases, with an estimated 42 million carriers nationwide. Every year, between 10,000 and 15,000 children are born with ...

BGI Genomics and Partner demonstrated the high efficiency of High-Throughput Sequencing (HTS) in preventing severe thalassemia birth defects. The findings were published in the Journal of Genetics and ...

Thalassemia is an inherited blood disorder that affects your body’s ability to produce hemoglobin and healthy red blood cells, making it extremely debilitating. According to experts, it leads you to ...

On January 21st, the Thalassemia International Federation (TIF) and BGI Genomics jointly hosted an educational webinar focused on thalassemia prevention in high-prevalence regions. The event featured ...

Bone marrow transplants are increasingly being used to treat non-cancer conditions like thalassemia and sickle cell disease, ...

A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers lessons learned to inform best practices as manufacturers and medical centers ...

A domestically developed gene-editing therapy has successfully treated patients with beta-thalassemia, allowing them to live without the need for lifelong blood transfusions, according to a study ...

Maharashtra minister Bhujbal’s chopper lands on Pune parking lot: What went wrong?

As conversations around marriage often revolve around finances, careers and lifestyle compatibility, a critical health ...